SCHEMBL18675574

SCHEMBL18675574

CNC(=O)[C@H]1S[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@@H](O)C1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 20/20 1.00
▸ ADORA1 P30542 9/20 1.00
▸ ADORA2A P29274 6/20 1.00
▸ PPARD Q03181 2/20 1.00
▸ PPARG P37231 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5369617 1.00 ADORA3 (1.00) ADORA3ADORA1ADORA2APPARDPPARG
SCHEMBL14316094 1.00 ADORA3 (1.00) ADORA3ADORA1ADORA2APPARDPPARG
SCHEMBL12264930 1.00 ADORA3 (1.00) ADORA3ADORA1ADORA2APPARDPPARG
SCHEMBL18675576 1.00 ADORA3 (1.00) ADORA3ADORA1ADORA2APPARDPPARG
SCHEMBL14296866 0.93 ADORA3 (0.86) ADORA3ADORA1ADORA2APPARDPPARG
SCHEMBL18675350 0.92 ADORA3 (0.85) ADORA3ADORA1ADORA2APPARDPPARG
SCHEMBL19464991 0.91 ADORA3 (0.84) ADORA3ADORA1ADORA2APPARDPPARG
SCHEMBL18675579 0.91 ADORA3 (0.84) ADORA3ADORA1ADORA2APPARDPPARG
SCHEMBL14316095 0.91 ADORA3 (0.84) ADORA3ADORA1ADORA2APPARDPPARG
SCHEMBL14325218 0.91 ADORA3 (0.83) ADORA3ADORA1ADORA2APPARDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9789131-B1 Compounds and methods for treating neurological and cardiovascular conditions ASTROCYTE PHARMACEUTICALS, INC. (US) 2017-10-17 — — US disclosed
WO-2017052322-A1 ADENOSINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING SAME AS ACTIVE INGREDIENT 퓨쳐메디신 주식회사 2017-03-30 — — WO disclosed
Send feedback